Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery

Thrombosis Research

Volumn 104, Issue 5, 2001, Pages 301-307

  Kojima, Taku ^a   Gando, Satoshi ^a   Morimoto, Yuji ^a   Mashio, Hideyuki ^b   Goda, Yukiko ^b   Kawahigashi, Hiroshi ^b   Kemmotsu, Osamu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Bleeding; Cardiopulmonary bypass (CPB); Fibrinolysis; Tranexamic acid

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIGEN; D DIMER; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLEEDING; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PERIOPERATIVE PERIOD; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKIN INCISION; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; CARDIOPULMONARY BYPASS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

EID: 0035644192     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00379-6     Document Type: Article

References (18)

1. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding
2. The international study of peri-operative transfusion (ISPOT) investigators. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
3. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
4. Bleeding complications associated with cardiopulmonary bypass
5. Tranexamic acid. A review of its use in surgery and other indications
6. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
7. Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery
8. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: A double-blind, randomized, placebo-controlled trial
9. Antifibirinolytic therapy with tranexamic acid in cardiac operations
10. Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation
11. The effects of cardiopulmonary bypass on fibrin formation and lysis: Is a normal fibrinolytic response essential?
12. Natural and synthetic antifibrinolytics in adult cardiac surgery: Efficacy, effectiveness and efficiency
13. Physiologic regulation and pathologic disorders of fibrinolysis
14. Plasminogen activators
15. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass
16. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma
17. Aprotinin. An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery
18. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin